These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 10815278

  • 1. [Comparison of candesartan, enalapril and their combination in congestive heart failure].
    Rapezzi C.
    Ital Heart J Suppl; 2000 Mar; 1(3):429-30. PubMed ID: 10815278
    [No Abstract] [Full Text] [Related]

  • 2. [ACE inhibitors or AT1 receptor antagonists?].
    Riegger GA.
    Dtsch Med Wochenschr; 1999 Sep 24; 124 Suppl 2():S37-9. PubMed ID: 10535045
    [No Abstract] [Full Text] [Related]

  • 3. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
    Franke H.
    J Hum Hypertens; 1997 Sep 24; 11 Suppl 2():S61-2. PubMed ID: 9331010
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 24; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 5. Candesartan for hypertension.
    Med Lett Drugs Ther; 1998 Nov 20; 40(1040):109-10. PubMed ID: 9844624
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG, Serbul VM, Ageev FT.
    Ter Arkh; 2009 Nov 20; 81(5):64-71. PubMed ID: 19537590
    [Abstract] [Full Text] [Related]

  • 7. Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.
    McKelvie RS, Rouleau JL, White M, Afzal R, Young JB, Maggioni AP, Held P, Yusuf S.
    Eur Heart J; 2003 Oct 20; 24(19):1727-34. PubMed ID: 14522567
    [Abstract] [Full Text] [Related]

  • 8. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
    Zanchetti A, Omboni S, Di Biagio C.
    J Hum Hypertens; 1997 Sep 20; 11 Suppl 2():S57-9. PubMed ID: 9331009
    [No Abstract] [Full Text] [Related]

  • 9. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure.
    Demers C, McKelvie RS, Negassa A, Yusuf S, RESOLVD Pilot Study Investigators.
    Am Heart J; 2001 Oct 20; 142(4):698-703. PubMed ID: 11579362
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [AT 1-blocker can be given in addition to ACE inhibitor and beta blocker. "Triple therapy decidedly well tolerated even in severe heart failure"].
    Dietz R.
    MMW Fortschr Med; 2004 May 27; 146(22):50. PubMed ID: 15373115
    [No Abstract] [Full Text] [Related]

  • 16. [Angiotensin receptor antagonist for therapy of patients with hypertension].
    Rakugi H, Ogihara T.
    Nihon Rinsho; 1997 Aug 27; 55(8):2075-80. PubMed ID: 9284426
    [Abstract] [Full Text] [Related]

  • 17. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA, Berezin AE.
    Ter Arkh; 2002 Aug 27; 74(1):52-5. PubMed ID: 11878061
    [Abstract] [Full Text] [Related]

  • 18. [CHARM study--new strategy for the treatment of heart failure].
    Hasegawa H, Komuro I.
    Nihon Rinsho; 2004 May 27; 62(5):995-1002. PubMed ID: 15148833
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin receptor blockade with candesartan in heart failure: findings from the Candesartan in Heart failure--assessment of reduction in mortality and morbidity (CHARM) programme.
    Ostergren JB.
    J Hypertens Suppl; 2006 Mar 27; 24(1):S3-7. PubMed ID: 16601570
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS, Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators.
    Am J Cardiol; 2005 Sep 01; 96(5):698-704. PubMed ID: 16125499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.